Literature DB >> 11864806

A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia.

Paul B Fitzgerald1, Timothy L Brown, Zafiris J Daskalakis, Jayashri Kulkarni.   

Abstract

It has been proposed that inhibitory deficits play a crucial role in the pathophysiological process of schizophrenia as suggested by post-mortem, neuropsychological and neurophysiological evidence. We hypothesised that patients with schizophrenia would demonstrate abnormalities of cortical inhibition in the motor cortex with single and paired pulse transcranial magnetic stimulation (TMS). Patients with DSM-IV schizophrenia (n=22) and normal volunteers (n=21) participated in the study. Electromyographic recordings from the abductor pollicis brevis (APB) muscle were made during focal TMS stimulation to the contra-lateral motor cortex. The threshold intensity to produce a motor response, the size of the motor evoked potential, the duration of the silent period, and the cortical inhibition and facilitation to paired pulse TMS were measured. The patient group demonstrated a reduction in length of the silent period and a reduction in cortical inhibition with paired stimuli. No changes were found in motor threshold, motor evoked potential size, or cortical facilitation. The study demonstrated deficits of cortical inhibition in the motor cortex of patients with schizophrenia. These deficits appear to be of cortical origin. Their relationship to dysfunction in other cortical networks requires further elucidation.

Entities:  

Mesh:

Year:  2002        PMID: 11864806     DOI: 10.1016/s0925-4927(02)00002-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  29 in total

Review 1.  Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.

Authors:  Natasha Radhu; Lakshmi N Ravindran; Andrea J Levinson; Zafiris J Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

2.  Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder.

Authors:  Margaret A Richter; Danilo R de Jesus; Sylco Hoppenbrouwers; Melissa Daigle; Jasna Deluce; Lakshmi N Ravindran; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

Review 3.  [Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation].

Authors:  T Wobrock; D Kadovic; P Falkai
Journal:  Nervenarzt       Date:  2007-07       Impact factor: 1.214

Review 4.  rTMS strategies for the study and treatment of schizophrenia: a review.

Authors:  Arielle D Stanford; Zafar Sharif; Cheryl Corcoran; Nina Urban; Dolores Malaspina; Sarah H Lisanby
Journal:  Int J Neuropsychopharmacol       Date:  2008-02-01       Impact factor: 5.176

5.  The EEG correlates of the TMS-induced EMG silent period in humans.

Authors:  Faranak Farzan; Mera S Barr; Sylco S Hoppenbrouwers; Paul B Fitzgerald; Robert Chen; Alvaro Pascual-Leone; Zafiris J Daskalakis
Journal:  Neuroimage       Date:  2013-06-22       Impact factor: 6.556

Review 6.  GABA abnormalities in schizophrenia: a methodological review of in vivo studies.

Authors:  Stephan F Taylor; Ivy F Tso
Journal:  Schizophr Res       Date:  2014-10-25       Impact factor: 4.939

7.  Aberrant Middle Prefrontal-Motor Cortex Connectivity Mediates Motor Inhibitory Biomarker in Schizophrenia.

Authors:  Xiaoming Du; Fow-Sen Choa; Joshua Chiappelli; Krista M Wisner; George Wittenberg; Bhim Adhikari; Heather Bruce; Laura M Rowland; Peter Kochunov; L Elliot Hong
Journal:  Biol Psychiatry       Date:  2018-06-21       Impact factor: 13.382

8.  Test-retest reliability of short-interval intracortical inhibition and intracortical facilitation in patients with schizophrenia.

Authors:  Xiaoming Du; L Elliot Hong
Journal:  Psychiatry Res       Date:  2018-06-19       Impact factor: 3.222

9.  Aberrant high-frequency desynchronization of cerebellar cortices in early-onset psychosis.

Authors:  Tony W Wilson; Erin Slason; Olivia O Hernandez; Ryan Asherin; Martin L Reite; Peter D Teale; Donald C Rojas
Journal:  Psychiatry Res       Date:  2009-09-23       Impact factor: 3.222

10.  Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.

Authors:  Thomas Wobrock; Alkomiet Hasan; Berend Malchow; Claus Wolff-Menzler; Birgit Guse; Nicolas Lang; Thomas Schneider-Axmann; Ullrich K H Ecker; Peter Falkai
Journal:  Psychopharmacology (Berl)       Date:  2009-12-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.